REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Latinoamericano De Investigaciones Oncologicas Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services | Nursing Care Facilities (Skilled Nursing Facilities)
Full name: Instituto Latinoamericano De Investigaciones Oncologicas Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Latinoamericano De Investigaciones Oncologicas Sas is a company based in Colombia, with its head office in Pasto. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on February 15, 2016. The company’s latest financial report indicates a net sales revenue drop of 79.87% in 2023. There was a total negative growth of 8.59% in Instituto Latinoamericano De Investigaciones Oncologicas Sas’s total assets over the same period. The net profit margin of Instituto Latinoamericano De Investigaciones Oncologicas Sas decreased by 8.25% in 2023.

Headquarters
Calle 22 No. 41 - 12 Oficina 204
Pasto; Narino;

Contact Details: Purchase the Instituto Latinoamericano De Investigaciones Oncologicas Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instituto Latinoamericano De Investigaciones Oncologicas Sas report to view the information.
Incorporation Date:
February 15, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Latinoamericano De Investigaciones Oncologicas Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-79.87%
Total operating revenue
-79.87%
Operating profit (EBIT)
-85.33%
EBITDA
-76.54%
Net Profit (Loss) for the Period
-87.38%
Total assets
-8.59%
Total equity
-11.44%
Operating Profit Margin (ROS)
-7.58%
Net Profit Margin
-8.25%
Return on Equity (ROE)
-6.89%
Quick Ratio
-55.86%
Cash Ratio
-5.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?